The IIM-Myology meeting October 12-15, 2017 to be held in Assisi, Italy is focused on the pathogenesis and therapy of rare muscle diseases. The program will have different sessions addressing current and future issues in Myology.
Dr. Uli Schmidt, President at Genea Biocells, will present a lecture entitled: “An in vitro model of FSHD based on human pluripotent stem cell-derived skeletal myotubes and its application in drug discovery.”
The final scientific program will include international speakers selected among submitted abstracts to favour presentation of unpublished, novel progresses. Special attention will be given to young investigators. A poster session will allow all participants to present and share their data.
Pathogenesis and Therapies of Rare Diseases topics include:
• Biophysics and E-C coupling
• Genetics and epigenetic
• Muscle stem cells and regenerative medicine
• Muscle wasting and cachexia
• Nutrition, exercise and well-being
• Signaling and metabolism
• Therapeutic approaches
For more information please visit: IIM .
September 26, 2017